Pear Therapeutics, Inc. (PEARQ)

Market Cap	887.73K
Revenue (ttm)	12.69M
Net Income (ttm)	-75.49M
Shares Out	138.71M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,883,930
Open	n/a
Previous Close	0.0064
Day's Range	n/a
52-Week Range	0.0016 - 0.0277
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PEARQ

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of product candidates focusing on psychiatry, neurology, and outside of central nervous system ther...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 200
• Stock Exchange: OTCMKTS
• Ticker Symbol: PEARQ

Financial Performance

In 2022, PEARQ's revenue was $12.69 million, an increase of 201.66% compared to the previous year's $4.21 million. Losses were -$75.49 million, 15.9% more than in 2021.